SVR Not Required to Benefit from Hepatitis C Treatment | Hepatitis Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Menu Search
Previous

Previous HCV Non-Responders Win in Phase III Telaprevir Study

Back to News Homepage
Next

Outlook Brightens for Chronic Hepatitis B

SVR Not Required to Benefit from Hepatitis C Treatment

The Editors at Hepatitis Central
September 22, 2010

Print this page

A Spanish study finds that even if a sustained viral response is not achieved with combination therapy, those who had a partial response to Hepatitis C treatment fared better than those with no response at all.

Partial Hep C Treatment Response Offers Health Benefits

September 17, 2010

Even a partial response to hepatitis C virus (HCV) therapy confers significant health benefits to people coinfected with both HIV and HCV, though not as much as a full response. These data were presented September 14 at the 50th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Boston.

The goal of HCV therapy is total eradication of the virus. This outcome, called a sustained virological response (SVR), means that a person achieves and maintains undetectable HCV levels for at least six months after completing a course of pegylated interferon and ribavirin treatment, which is the standard of care for hepatitis C. People who achieve an SVR are generally considered to be “cured” of their HCV infection.

Continue reading this entire article:
http://www.aidsmeds.com/articles/hiv_hcv_hepatitis_1667_19116.shtml

No Comments - be the first!
Share
Share
Previous

Previous HCV Non-Responders Win in Phase III Telaprevir Study

Back to News Homepage
Next

Outlook Brightens for Chronic Hepatitis B

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.